Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
6.1 EUR | -1.13% | -6.30% | -8.13% |
May. 22 | Nanobiotix: strategy update, share price declines | CF |
May. 21 | Nanobiotix to Transfer Phase 3 Head and Neck Cancer Study Sponsorship | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.13% | 316M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+42.72% | 40.47B | |
-10.02% | 27.17B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- NANO Stock
- News Nanobiotix
- Nanobiotix Prices $55 Million Share Sale in US, Europe; Paris Stock Closes Lower